Phase 4 N=119 Clinical Investigation of the Vision-R800 Device.
Myopia · Hyperopia · Astigmatism
Primary: Subjective Questionnaire Response — 22; 32; 5; 3 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=432 Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies and Lung Transplantation Outcomes
Heart Transplant Surgery · Lung Transplant Surgery
Primary: Number of Participants With Grade 3 Primary Graft Dysfunction (PGD) for Lung Transplant Subjects — 39; 46 Participants — p=0.019
Phase 4 N=43 Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
Adverse Effect · Atherosclerosis, Coronary · Insulin Resistance Syndrome
Primary: Сardiovascular Death — 0; 0; 0; 0 Participants
Phase 4 N=19 Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata
Alopecia Areata
Primary: Number of Responders vs Non-Responders Using SALT Score — 9; 10 Participants
Phase 4 N=35 Engagement With an Adaptive Mobile Health Smoking Cessation Intervention
Tobacco Use Cessation
Primary: Number of Participants With Self-reported 7-day Abstinence From Smoking at 12 Weeks — 0; 1; 1; 4 Participants
Phase 4 N=68 Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD
Polycystic Kidney, Autosomal Dominant
Primary: Percent Change in Brachial Artery Flow-mediated Dilation (FMD-BA) — 1.14; 0.3 percent change
Phase 4 N=191 Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
HIV Infections
Primary: Change in Normalized Composite Neurocognitive Test Score at Week 48 From Baseline — 0.20; 0.26; 0.31 total neurocognitive z-score — p=0.60
Phase 4 N=100 Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation
Induced Abortion
Primary: Initial Cervical Dilation — 11.7; 10.9 mm
Phase 4 N=30 Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422)
Allergic Rhinitis
Primary: Comparison of Systemic Exposure Measured by AUC, ng*hr/L, (Area Under the Serum Concentration) of Des-ciclesonide With Ciclesonide Nasal Spray, and Ciclesonide HFA Nasal…
Phase 4 N=58 Sonographic Hysterosalpingography: Oil vs Water Based Media (SHOW Trial)
Infertility
Primary: Ongoing Pregnancy Rate — 9; 4 Participants — p=0.10
Phase 4 N=6 Lofexidine for Adults Undergoing Lumbar Spine Surgery
Opioid Withdrawal
Primary: Opioid Tapering — 5 Participants
Phase 4 N=60 Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study-STAT Study
Diabetes Mellitus, Type 1
Primary: Change in Time in Range (%) (70-180 mg/dl) With TI on CGM — 53.5; 58.4 percent time in range
Phase 4 N=20 Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
ART · HIV
Primary: Median Drug Levels in Plasma — 0; 0; 0; 0 ng/mL
Phase 4 N=480 Immunogenicity of Hepatitis B Vaccination Among Drug Users
Hepatitis B Vaccination
Primary: Number and Rate of Participants With Anti-HBs Seroconversion at Month 7 — 142; 138; 0 Participants
Phase 4 N=610 Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery
Post-operative Urinary Retention
Primary: Number of Patients Who Undergo Postoperative Catheterization for Urinary Retention — 23; 25 Participants — p=.96